Skip to main content
Article
Transposed Basilic Vein Versus Polytetrafluorethylene for Brachial-Axillary Arteriovenous Fistulas
The American Journal of Surgery
  • John H. Matsuura, Wright State University
  • David Rosenthal
  • Michael D. Clark
  • Frederick W. Shuler
  • Lem Kirby
  • Michael Shotwell
  • Jerry Purvis
  • L. Laszlo Pallos
Document Type
Article
Publication Date
8-1-1998
Abstract

Background: Both transposed basilic vein (BV) and polytetrafluorethylene (PTFE) upper arm arteriovenous fistulas (AVF) are common angioaccess operations. To evaluate the patency and complication rates after AVF, a concurrent series of patients was reviewed.

Methods: Ninety-eight patients underwent brachial artery to axillary vein AVF: 30 BV and 68 PTFE. The PTFE grafts were performed in the standard fashion, whereas the basilic veins were translocated subcutaneously to the brachial artery.

Results: Risk factors were similar between the two groups. Basilic vein AVF had better patency at 24 months (70% BV versus 46% PTFE, P = 0.023). The dialysis access complications were higher in the BV group (20%) versus PTFE (5%), but the PTFE group had a higher infection rate (10%) than BV (0%).

Conclusions: The primary and secondary patency rates were superior in the BV AVFs. The BV AVF preserves the venous outflow tract after AVF thrombosis for a future PTFE AVF operation.

Comments

Presented at the 26th Annual Symposium on Vascular Surgery, Society for Clinical Vascular Surgery, San Diego, California, March 25–29, 1998.

DOI
10.1016/S0002-9610(98)00122-6
Citation Information
John H. Matsuura, David Rosenthal, Michael D. Clark, Frederick W. Shuler, et al.. "Transposed Basilic Vein Versus Polytetrafluorethylene for Brachial-Axillary Arteriovenous Fistulas" The American Journal of Surgery Vol. 176 Iss. 2 (1998) p. 219 - 221 ISSN: 0002-9610
Available at: http://works.bepress.com/john_matsuura/34/